Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pancreatic carcinogenesis. Clinical implications].

G Schneider1, C Lersch, R M Schmid

  • 1II. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Munich.

Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|March 21, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In vivo monitoring of splenocytes in NMRI nu/nu- and nu/+,- mice during Lewis lung tumor progression or regression.

International journal of oncology·2011
Same author

Microcirculation of subepithelial gastric tumors using contrast-enhanced ultrasound.

Clinical hemorheology and microcirculation·2010
Same author

[Endothelial adrenal cyst mimicking cystic echinococcosis in a Turkish woman].

Zeitschrift fur Gastroenterologie·2008
Same author

Capecitabine for treatment of advanced hepatocellular carcinoma.

Hepato-gastroenterology·2008
Same author

[Contrast media-enhanced and B-imaging ultrasound as a diagnostic and follow-up tool of hepatic echinococcosis in a 19-year-old Turkish woman].

Deutsche medizinische Wochenschrift (1946)·2007
Same author

Squamous-cell carcinoma of the duodenum as a rare cause of upper gastrointestinal bleeding.

Endoscopy·2006
Same journal

[S3 Guideline "Adult soft tissue sarcomas"].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Synopsis-S3 guidelines pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Laparoscopic sentinel node navigation surgery in gastric cancer to reduce surgical radicality].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[ASCO guidelines for the treatment of stage III NSCLC part 4: indications for adjuvant therapy].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Surgical treatment of pancreatic cancer-What is new?]

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
See all related articles

Sophisticated molecular techniques reveal pancreatic cancer's molecular oncogenesis. Understanding genetic mutations and epigenetic alterations offers potential therapeutic targets for this disease.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Pancreatic cancer molecular pathology understanding has advanced significantly.
  • Sophisticated molecular techniques have enabled new insights.
  • A pancreatic tumor progression model has been proposed.

Purpose of the Study:

  • To describe the molecular oncogenesis of pancreatic carcinoma.
  • To identify potential therapeutic targets for pancreatic cancer.
  • To highlight the role of genetic and epigenetic alterations.

Main Methods:

  • Analysis of molecular pathology.
  • Review of genetic mutations (K-RAS, INK4a, TP53, DPC4/SMAD4).
  • Assessment of epigenetic alterations (e.g., epidermal growth factor receptor/ligand system).

Related Experiment Videos

Main Results:

  • Pancreatic cancer involves sequential acquisition of somatic mutations.
  • Epigenetic alterations, including receptor/ligand system overexpression, are implicated.
  • Genetic changes disrupt cell cycle regulation and promote continuous growth.

Conclusions:

  • Further molecular mechanism analysis is crucial.
  • New diagnostic and therapeutic options may emerge.
  • Improved outcomes for pancreatic cancer patients are a future goal.